07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TPNT<br />

82428<br />

TROT<br />

82788<br />

"Tropheryma whippleii " and its use for detection of "T. whipplei" in clinical specimens by PCR. J Clin<br />

Microbiol 2000;38:2248-2253 3. Sloan LM, Rosenblatt JE, Cockerill FR 3rd. Detection of Tropheryma<br />

whipplei DNA in clinical specimens by LightCycler real-time PCR. J Clin Microobiol. 2005;43:3516-8 4.<br />

von Herbay A, Ditton HJ, Schuhmacher F, et al: Whipple's disease: staging and monitoring by cytology<br />

and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology 1997;113(2):434-441<br />

Troponin T, Serum<br />

Clinical Information: Troponin T is a myofibrillar protein found in striated musculature. There are 2<br />

types of myofilament, a thick filament containing myosin and a thin filament consisting of 3 different<br />

proteins: actin, tropomyosin, and troponin. Troponin is itself a complex of 3 protein subunits: troponin T,<br />

troponin I, and troponin C. Troponin T binds the troponin complex to tropomyosin. Troponin I inhibits<br />

actomyosin ATPase in relation to the calcium concentration. Troponin C, with its 4 binding sites for<br />

calcium, mediates calcium dependency. In the cytosol, troponin T is found in both free and protein-bound<br />

forms. The unbound (free) pool of troponin T is the source of the troponin T released in the early stages of<br />

myocardial damage. Bound troponin T is released from the structural elements at a later stage,<br />

corresponding with the degradation of myofibrils that occurs in irreversible myocardial damage. The most<br />

common cause of cardiac injury is myocardial ischemia, ie, acute myocardial infarction. Troponin T<br />

becomes elevated 2 to 4 hours after the onset of myocardial necrosis, and can remain elevated for up to 14<br />

days. Elevations in troponin T are also seen in patients with unstable angina. The finding of unstable<br />

angina and an elevated troponin T are known to have adverse short- and long-term prognoses, as well as a<br />

unique beneficial response to an invasive interventional strategy and treatment with the newer antiplatelet<br />

agents and low-molecular-weight heparin.<br />

Useful For: Exclusion diagnosis of acute myocardial infarction Monitoring acute coronary syndromes<br />

and estimating prognosis Possible utility in monitoring patients with nonischemic causes of cardiac injury<br />

Troponin T is the cardiac marker of choice for the <strong>Mayo</strong> Health System for the evaluation of patients with<br />

possible cardiovascular injury<br />

Interpretation: The upper limit for normal individuals is or =0.01 ng/mL that are<br />

rising make the diagnosis of cardiac injury. Decreasing values are indicative of recent cardiac injury.<br />

Troponin T values > or =0.01 ng/mL are a prognostic sign in patients with ischemic heart disease and<br />

most other situations. Clinical judgment is necessary to distinguish patients who have ischemic heart<br />

disease from those who do not. However, all patients with > or =0.01 ng/mL troponin T are at increased<br />

risk for cardiac events relative to patients with undetectable troponin T. Patients with low level ( or =0.01 ng/mL<br />

troponin T are at increased risk for cardiac events relative to patients with undetectable troponin T.<br />

Reference Values:<br />

or =0.01 ng/mL have been shown to have prognostic value.<br />

Clinical References: Jaffe AS: 2001-A biomarker odyssey. Clin Chim Acta 1999;284:197-211<br />

Trout, IgE<br />

Clinical Information: Clinical manifestations of immediate hypersensitivity (allergic) diseases are<br />

caused by the release of proinflammatory mediators (histamine, leukotrienes, and prostaglandins) from<br />

immunoglobulin E (IgE)-sensitized effector cells (mast cells and basophils) when cell-bound IgE<br />

antibodies interact with allergen. In vitro serum testing for IgE antibodies provides an indication of the<br />

immune response to allergen(s) that may be associated with allergic disease. The allergens chosen for<br />

testing often depend upon the age of the patient, history of allergen exposure, season of the year, and<br />

clinical manifestations. In individuals predisposed to develop allergic disease(s), the sequence of<br />

sensitization and clinical manifestations proceed as follows: eczema and respiratory disease (rhinitis and<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 1797

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!